Eur Radiol Suppl (2006) 16 (Suppl 1) : 150
During preparation of the manuscript for publication, it was discovered that the large patient database, which formed the basis for the findings we presented at ECR 2006 [as published in abstract B058 Section: B – Scientific Sessions, page 150], inadvertently included an undetermined number of patients who did not receive any contrast. In our analysis, it was assumed that all patients received either Gd-DTPA (Magnevist®) or Gd-DTPABMA (Omniscan®). However, in both groups some patients received no contrast in conjunction with their MRI exam. As a result of this error, which became known only after the abstract was published, we believe that our findings and conclusions as reported in the abstract need to be re-evaluated.
At this point, the data presented do not allow for any final conclusions regarding the interference of Gd-DTPA or Gd-DTPA-BMA with colorimetric serum calcium measurements, or regarding the incidence of spurious hypocalcemia after administration of either of the two MR contrast agents. We are currently re-analyzing the data and will report those results in the near future.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original can be found athttp://dx.doi.org/10.1007/s10406-006-0175-4
Rights and permissions
About this article
Cite this article
Nguyen, M., Klassen, C., Kareti, K. et al. Spurious hypocalcemia caused by interference of MR contrast agents with serum calcium colorimetric measurement technique. Eur Radiol Suppl (2006). https://doi.org/10.1007/s10406-006-0188-z
Published:
DOI: https://doi.org/10.1007/s10406-006-0188-z